Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

8.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine Diagnostics.

Pathobiology : journal of immunopathology, molecular and cellular biology·2022
Same author

The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas.

Frontiers in oncology·2021
Same author

Nestin and CD34 expression in colorectal cancer predicts improved overall survival.

Acta oncologica (Stockholm, Sweden)·2021
Same author

Infiltration by IL22-Producing T Cells Promotes Neutrophil Recruitment and Predicts Favorable Clinical Outcome in Human Colorectal Cancer.

Cancer immunology research·2020
Same author

Corrigendum to "HMGA1 expression in human hepatocellular carcinoma correlates with poor prognosis and promotes tumor growth and migration in in vitro models" [Neoplasia 18 (2016) 724-731].

Neoplasia (New York, N.Y.)·2020
Same author

Low Expression of Programmed Death 1 (PD-1), PD-1 Ligand 1 (PD-L1), and Low CD8+ T Lymphocyte Infiltration Identify a Subgroup of Patients With Gastric and Esophageal Adenocarcinoma With Severe Prognosis.

Frontiers in medicine·2020

Related Experiment Video

Updated: Apr 18, 2026

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
07:21

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Published on: May 2, 2022

2.7K

Gastrointestinal stromal tumor - an evolving concept.

Luigi Tornillo1

  • 1Institute of Pathology, University of Basel , Basel , Switzerland.

Frontiers in Medicine
|January 17, 2015
PubMed
Summary

Gastrointestinal stromal tumors (GISTs) are linked to specific gene mutations, guiding targeted therapy. Understanding molecular status is crucial for predicting treatment response and classifying these mesenchymal tumors.

Keywords:
CKITgastrointestinal stromal tumorsgastrointestinal tractreceptor tyrosine kinasetargeted therapy

More Related Videos

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
06:43

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

Published on: April 3, 2026

116
Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
05:16

Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors

Published on: February 19, 2022

6.8K

Related Experiment Videos

Last Updated: Apr 18, 2026

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
07:21

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Published on: May 2, 2022

2.7K
Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
06:43

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

Published on: April 3, 2026

116
Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
05:16

Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors

Published on: February 19, 2022

6.8K

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the GI tract.
  • GISTs were previously misclassified as smooth muscle tumors.
  • Recent discoveries link GISTs to specific mutations in receptor tyrosine kinases (RTKs) like CKIT and PDGFRA.

Purpose of the Study:

  • To highlight the importance of molecular profiling in GISTs.
  • To emphasize the role of RTK mutations in predicting targeted therapy response.
  • To discuss the evolving classification of GISTs based on molecular data.

Main Methods:

  • Analysis of GIST molecular profiles.
  • Correlation of mutational status with clinical outcomes.
  • Integration of molecular data with clinico-morphological characteristics.

Main Results:

  • Activating mutations in CKIT and PDGFRA are key drivers of GISTs.
  • Mutational status strongly predicts response to RTK inhibitor therapy.
  • Alternative oncogenic events (e.g., SDH, IGF, RAS-RAF-MAPK pathway) are identified in therapy-resistant cases.

Conclusions:

  • GIST classification now requires integrating molecular data with clinico-morphological features.
  • Molecular information is essential for personalized GIST treatment planning.
  • GISTs serve as a prime example of molecular insights driving clinical practice.